Tags: Drug.

Arbekacin (INN) is a semisynthetic aminoglycoside antibiotic. It is primarily used for the treatment of infections caused by multi-resistant bacteria including methicillin-resistant Staphylococcus aureus (MRSA). Arbekacin was originally synthesized from dibekacin in 1973. It has been registered and marketed in Japan since 1990 under the trade name Habekacin.

Arbekacin.png
ATC prefix
J01
ATC suffix
GB12
CAS number
51025-85-5
DrugBank
DB06696
FDA UNII code
G7V6SLI20L
IUPAC name
(2S)-4-amino-N-[(1R2S3R4R5S)-5-amino-2-[(2S3R4S5S6R)-4-amino-35-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R3R6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide
PubChem
11398765

Loading...

This page contains content from the copyrighted Wikipedia article "Arbekacin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.